Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 05, 2021 at 05:14 pm EDT
Share
Ouro Fino Saúde Animal Participações S.A.Announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was BRL 230.981 million compared to BRL 172.535 million a year ago. Operating income was BRL 43.182 million compared to BRL 12.070 million a year ago. Net income was BRL 31.983 million compared to BRL 14.734 million a year ago. For the half year, sales was BRL 399.765 million compared to BRL 284.414 million a year ago. Operating income was BRL 61.640 million compared to BRL 12.416 million a year ago. Net income was BRL 41.474 million compared to BRL 12.579 million a year ago.
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. 
